Aspirin resistance

Advances in Hematology

Volumn 2009, Issue , 2009, Pages

  Alam, Samir ^a   Mansour, Khaled ^a   Taher, Ali T ^a   Musallam, Khaled M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CREATINE KINASE MB; GLUCOSE; HEMOGLOBIN A1C; TROPONIN I;

ASPIRIN RESISTANCE; BLOOD CLOTTING PARAMETERS; BODY WEIGHT; CORONARY ARTERY DISEASE; DRUG ABSORPTION; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; GENETIC POLYMORPHISM; HIGH RISK PATIENT; HUMAN; INCIDENCE; LABORATORY TEST; LOW DRUG DOSE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 77953371623     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2009/937352     Document Type: Review

References (96)

1. The Second International Study of Infarct Survival Collaborative Group, Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 The Lancet 1988 2 8607 349 360
2. Antithrombotic Trialists Collaboration, Collaborative overview of randomised trials of antiplatelet therapyII: maintenance of vascular graft or arterial patency by antiplatelet therapy British Medical Journal 1994 308 6922 159 168 (Pubitemid 24979775)
3. Antithrombotic Trialists Collaboration, Collaborative overview of randomised trials of antiplatelet therapyIII: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients British Medical Journal 1994 308 6923 235 246
4. Baigent C., Sudlow C., Collins R., Peto R., Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients British Medical Journal 2002 324 7329 71 86 (Pubitemid 34073138)
5. Marson P., Pasero G., The Italian contributions to the history of salicylates Reumatismo 2006 58 1 66 75 (Pubitemid 46785289)
6. Lvesque H., Lafont O., Aspirin throughout the ages: an historical review La Revue de Mdecine Interne 2000 21 supplement 1 S8 S17
7. Vane J. R., The fight against rheumatism: from willow bark to COX-1 sparing drugs Journal of Physiology and Pharmacology 2000 51 4, part 1 573 586
8. Vainio H., Morgan G., Aspirin for the second hundred years: new uses for an old drug Pharmacology and Toxicology 1997 81 4 151 152 (Pubitemid 27432567)
9. Patrono C., Garca Rodrguez L. A., Landolfi R., Baigent C., Low-dose aspirin for the prevention of atherothrombosis The New England Journal of Medicine 2005 353 22 2373 2383 (Pubitemid 41713749)
10. Michelson A. D., Cattaneo M., Eikelboom J. W., Aspirin resistance: position paper of the Working Group on Aspirin Resistance Journal of Thrombosis and Haemostasis 2005 3 6 1309 1311 (Pubitemid 41725257)
11. Hankey G. J., Eikelboom J. W., Aspirin resistance The Lancet 2006 367 9510 606 617 (Pubitemid 43250663)
12. Wang T. H., Bhatt D. L., Topol E. J., Aspirin and clopidogrel resistance: an emerging clinical entity European Heart Journal 2006 27 6 647 654
13. Michos E. D., Ardehali R., Blumenthal R. S., Lange R. A., Ardehali H., Aspirin and clopidogrel resistance Mayo Clinic Proceedings 2006 81 4 518 526
14. Michelson A. D., Platelet function testing in cardiovascular diseases Circulation 2004 110 19 e489 e493
15. Hennekens C. H., Schror K., Weisman S., FitzGerald G. A., Terms and conditions: semantic complexity and aspirin resistance Circulation 2004 110 12 1706 1708 (Pubitemid 39297997)
16. Mehta J., Mehta P., Burger C., Pepine C. J., Platelet aggregation studies in coronary artery disease: past 4. Effect of aspirin Atherosclerosis 1978 31 2 169 175 (Pubitemid 9042840)
17. Gurbel P. A., Tantry U. S., Clopidogrel resistance? Thrombosis Research 2007 120 3 311 321
18. Andr P., Delaney S. M., LaRocca T., P 2 Y 12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries The Journal of Clinical Investigation 2003 112 3 398 406 (Pubitemid 38063768)
19. Sanderson S., Emery J., Baglin T., Kinmonth A.-L., Narrative review: aspirin resistance and its clinical implications Annals of Internal Medicine 2005 142 5 370 380 (Pubitemid 40293410)
20. Macchi L., Sorel N., Christiaens L., Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance Current Pharmaceutical Design 2006 12 2 251 258
21. Shantsila E., Watson T., Lip G. Y. H., Aspirin resistance: what, why and when? Thrombosis Research 2007 119 5 551 554 (Pubitemid 46304075)
22. Poulsen T. S., Jrgensen B., Korsholm L., Licht P. B., Haghfelt T., Mickley H., Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction Thrombosis Research 2007 119 5 555 562 (Pubitemid 46321503)
23. Grau A. J., Reiners S., Lichy C., Buggle F., Ruf A., Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study Stroke 2003 34 4 849 854 (Pubitemid 36402949)
24. Ziegler S., Maca T., Alt E., Speiser W., Schneider B., Minar E., Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients Platelets 2002 13 8 493 497 (Pubitemid 35373664)
25. Grundmann K., Jaschonek K., Kleine B., Dichgans J., Topka H., Aspirin non-responder status in patients with recurrent cerebral ischemic attacks Journal of Neurology 2003 250 1 63 66 (Pubitemid 36206686)
26. Macchi L., Christiaens L., Brabant S., Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate Thrombosis Research 2002 107 1-2 45 49 (Pubitemid 35284424)
27. ten Berg J. M., Gerritsen W. B. M., Haas F. J. L. M., Kelder H. C., Verheugt F. W. A., Thijs Plokker H. W., High-dose aspirin in addition to daily low-dose aspirin decreases platelet activation in patients before and after percutaneous coronary intervention Thrombosis Research 2002 105 5 385 390 (Pubitemid 34621255)
28. Gum P. A., Kottke-Marchant K., Poggio E. D., Profile and prevalence of aspirin resistance in patients with cardiovascular disease American Journal of Cardiology 2001 88 3 230 235 (Pubitemid 32721947)
29. Andersen K., Hurlen M., Arnesen H., Seljeflot I., Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease Thrombosis Research 2002 108 1 37 42 (Pubitemid 36197660)
30. Harrison P., Segal H., Blasbery K., Furtado C., Silver L., Rothwell P. M., Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry Stroke 2005 36 5 1001 1005 (Pubitemid 40629292)
31. Yee D. L., Dinu B. R., Sun C. W., Low prevalence and assay discordance of aspirin resistance in children Pediatric Blood Cancer 2008 51 1 86 92
32. Christiaens L., Ragot S., Mergy J., Allal J., Macchi L., Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study Blood Coagulation Fibrinolysis 2008 19 3 235 239 (Pubitemid 351498729)
33. Pamukcu B., Oflaz H., Onur I., Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR) Blood Coagulation Fibrinolysis 2007 18 2 187 192 (Pubitemid 46232841)
34. Pamukcu B., Oflaz H., Oncul A., The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events Journal of Thrombosis and Thrombolysis 2006 22 2 103 110 (Pubitemid 44473559)
35. Akay O. M., Canturk Z., Akin E., Bal C., Gulbas Z., Aspirin-resistance frequency: a prospective study in 280 healthy Turkish volunteers Clinical and Applied Thrombosis/Hemostasis 2009 15 1 98 102
36. Lee P.-Y., Chen W.-H., Ng W., Low-dose aspirin increases aspirin resistance in patients with coronary artery disease The American Journal of Medicine 2005 118 7 723 727 (Pubitemid 40897657)
37. Rao G. H. R., Influence of anti-platelet drugs on platelet-vessel wall interactions Prostaglandins, Leukotrienes and Medicine 1987 30 2-3 133 145
38. Koutts J., Aspirin and coronary heart disease. Clinical applications Australian Family Physician 1990 19 2 217, 221 223
39. Louden K. A., Pipkin F. B., Heptinstall S., Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin British Journal of Obstetrics and Gynaecology 1994 101 3 203 208 (Pubitemid 24197164)
40. Bucchi F., Bodzento A., de Gaetano G., Cerletti C., Effects of 1 gram oral or intravenous aspirin on urinary excretion of thromboxane B2 and 6-keto-PGF1 in healthy subjects Prostaglandins 1986 32 5 691 701 (Pubitemid 17232142)
41. Frlich J. C., A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes Trends in Pharmacological Sciences 1997 18 1 30 34
42. Cotter G., Shemesh E., Zehavi M., Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? American Heart Journal 2004 147 2 293 300 (Pubitemid 38176831)
43. Biondi-Zoccai G. G. L., Lotrionte M., Agostoni P., A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease European Heart Journal 2006 27 22 2667 2674 (Pubitemid 44729867)
44. Rottlaender D., Scherner M., Schneider T., Erdmann E., Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany Deutsche Medizinische Wochenschrift 2007 132 4 139 144 (Pubitemid 46405884)
45. Catella-Lawson F., Reilly M. P., Kapoor S. C., Cyclooxygenase inhibitors and the antiplatelet effects of aspirin The New England Journal of Medicine 2001 345 25 1809 1817
46. Anand B. S., Sanduja S. K., Lichtenberger L. M., Effect of omeprazole on the bioavailability of aspirin: a randomized controlled study on healthy volunteers Gastroenterology 1999 116 A371
47. Iarrea P., Esteva F., Cornudella R., Lanas A., Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man Scandinavian Journal of Gastroenterology 2000 35 3 242 246 (Pubitemid 30217174)
48. Halushka M. K., Halushka P. V., Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A 2 ? Circulation 2002 105 14 1620 1622
49. Eikelboom J. W., Hirsh J., Weitz J. I., Johnston M., Yi Q., Yusuf S., Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 2002 105 14 1650 1655 (Pubitemid 34298607)
50. Goodman T., Ferro A., Sharma P., Pharmacogenetics of aspirin resistance: a comprehensive systematic review British Journal of Clinical Pharmacology 2008 66 2 222 232 (Pubitemid 351991440)
51. Szczeklik A., Undas A., Sanak M., Frolow M., Wgrzyn W., Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa British Journal of Haematology 2000 110 4 965 967
52. Papp E., Havasi V., Bene J., Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation? Annals of Pharmacotherapy 2005 39 6 1013 1018 (Pubitemid 40695965)
53. Dropinski J., Musial J., Sanak M., Wgrzyn W., Nizankowski R., Szczeklik A., Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease Thrombosis Research 2007 119 3 301 303 (Pubitemid 44920432)
54. Cohen H. W., Crandall J. P., Hailpern S. M., Billett H. H., Aspirin resistance associated with HbA1c and obesity in diabetic patients Journal of Diabetes and Its Complications 2008 22 3 224 228
55. Ogawa H., Nakayama M., Morimoto T., Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial Journal of the American Medical Association 2008 300 18 2134 2141
56. Belch J., MacCuish A., Campbell I., The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease British Medical Journal 2008 337 a1840
57. Zimmermann N., Wenk A., Kim U., Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 2003 108 5 542 547 (Pubitemid 36961167)
58. Zimmermann N., Kurt M., Wenk A., Winter J., Gams E., Hohlfeld T., Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? European Journal of Cardio-Thoracic Surgery 2005 27 4 606 610 (Pubitemid 40409731)
59. Guthikonda S., Lev E. I., Patel R., Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin Journal of Thrombosis and Haemostasis 2007 5 3 490 496 (Pubitemid 46680680)
60. Modica A., Karlsson F., Mooe T., Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection Journal of Thrombosis and Haemostasis 2007 5 3 507 511 (Pubitemid 46680683)
61. Harrison P., Platelet function analysis Blood Reviews 2005 19 2 111 123 (Pubitemid 39643116)
62. Nicholson N. S., Panzer-Knodle S. G., Haas N. F., Assessment of platelet function assays American Heart Journal 1998 135 5, part 2 S170 S178
63. Gum P. A., Kottke-Marchant K., Poggio E. D., Profile and prevalence of aspirin resistance in patients with cardiovascular disease American Journal of Cardiology 2001 88 3 230 235 (Pubitemid 32721947)
64. Mammen E. F., Comp P. C., Gosselin R., PFA-100 TM system: a new method for assessment of platelet dysfunction Seminars in Thrombosis and Hemostasis 1998 24 2 195 202 (Pubitemid 28180831)
65. Christiaens L., Ragot S., Mergy J., Allal J., Macchi L., Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study Blood Coagulation Fibrinolysis 2008 19 3 235 239 (Pubitemid 351498729)
66. Coleman J. L., Wang J. C., Simon D. I., Determination of individual response to aspirin therapy using the Accumetrics Ultegra RFPA-ASA system Point of Care 2004 3 2 77 82
67. Nielsen H. L., Kristensen S. D., Thygesen S. S., Aspirin response evaluated by the VerifyNow TM Aspirin System and Light Transmission Aggregometry Thrombosis Research 2008 123 2 267 273
68. Hart R. G., Leonard A. D., Talbert R. L., Aspirin dosage and thromboxane synthesis in patients with vascular disease Pharmacotherapy 2003 23 5 579 584
69. Bruno A., McConnell J. P., Cohen S. N., Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction Stroke 2004 35 3 727 730 (Pubitemid 38280849)
70. Lordkipanidz M., Pharand C., Schampaert E., Turgeon J., Palisaitis D. A., Diodati J. G., A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease European Heart Journal 2007 28 14 1702 1708 (Pubitemid 47227104)
71. Krasopoulos G., Brister S. J., Beattie W. S., Buchanan M. R., Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis British Medical Journal 2008 336 7637 195 198 (Pubitemid 351212675)
72. Snoep J. D., Hovens M. M. C., Eikenboom J. C. J., van der Bom J. G., Huisman M. V., Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Archives of Internal Medicine 2007 167 15 1593 1599
73. Englyst N. A., Horsfield G., Kwan J., Byrne C. D., Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity Journal of Cerebral Blood Flow and Metabolism 2008 28 6 1196 1203 (Pubitemid 351733359)
74. Chen W.-H., Cheng X., Lee P.-Y., Aspirin resistance and adverse clinical events in patients with coronary artery disease The American Journal of Medicine 2007 120 7 631 635 (Pubitemid 46977320)
75. Chen W.-H., Lee P.-Y., Ng W., Tse H.-F., Lau C.-P., Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment Journal of the American College of Cardiology 2004 43 6 1122 1126 (Pubitemid 38353000)
76. Frossard M., Fuchs I., Leitner J. M., Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 2004 110 11 1392 1397 (Pubitemid 39238016)
77. Campo G., Valgimigli M., Gemmati D., Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention. Insights into the STRATEGY study Journal of the American College of Cardiology 2006 48 11 2178 2185 (Pubitemid 44873056)
78. Barone-Rochette G., Ormezzano O., Polack B., Vanzetto G., Bertrand B., Machecourt J., Resistance to platelet antiaggregants: an important cause of very late thrombosis of drug eluting stents? Observations from five cases Archives of Cardiovascular Diseases 2008 101 2 100 107 (Pubitemid 351467538)
79. Faraday N., Yanek L. R., Mathias R., Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 Circulation 2007 115 19 2490 2496 (Pubitemid 46763222)
80. Assadian A., Lax J., Meixner-Loicht U., Hagmller G. W., Bayer P. M., Hbl W., Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition Journal of Vascular Surgery 2007 45 6 1142 1147 (Pubitemid 46817833)
81. Fitzgerald D. J., Maree A., Aspirin and clopidogrel resistance Hematology 2007 2007 1 114 120
82. Lee P.-Y., Chen W.-H., Ng W., Low-dose aspirin increases aspirin resistance in patients with coronary artery disease The American Journal of Medicine 2005 118 7 723 727 (Pubitemid 40897657)
83. Derry S., Loke Y. K., Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis British Medical Journal 2000 321 7270 1183 1187
84. Campbell C. L., Smyth S., Montalescot G., Steinhubl S. R., Aspirin dose for the prevention of cardiovascular disease: a systematic review Journal of the American Medical Association 2007 297 18 2018 2024 (Pubitemid 46740354)
85. Borna C., Lazarowski E., van Heusden C., hlin H., Erlinge D., Resistance to aspirin in increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels Thrombosis Journal 2005 3, article 10 1 9
86. Eikelboom J. W., Hankey G. J., Thom J., Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial Journal of Thrombosis and Haemostasis 2005 3 12 2649 2655 (Pubitemid 41819791)
87. Wang T. H., Bhatt D. L., Fox K. A. A., An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial European Heart Journal 2007 28 18 2200 2207
88. Bhatt D. L., Flather M. D., Hacke W., Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial Journal of the American College of Cardiology 2007 49 19 1982 1988 (Pubitemid 46694290)
89. The ESPS-2 Group, European stroke prevention study 2: efficacy and safety data Journal of the Neurological Sciences 1997 151 supplement 1 S1 S77
90. Halkes P. H., van Gijn J., Kappelle L. J., Koudstaal P. J., Algra A., Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial The Lancet 2006 367 9523 1665 1673
91. De Schryver E., Algra A., van Gijn J., Dipyridamole for preventing stroke and other vascular events in patients with vascular disease Cochrane Database of Systematic Reviews 2007 18 3
92. Boncoraglio G. B., Bodini A., Brambilla C., Corsini E., Carriero M. R., Parati E. A., Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease Clinical Neurology and Neurosurgery 2009 111 3 270 273
93. Gent M., A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) The Lancet 1996 348 9038 1329 1339 (Pubitemid 26383772)
94. Sacco R. L., Adams R., Albers G., Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke: co-sponsored by the council on cardiovascular radiology and intervention. The American Academy of Neurology affirms the value of this guideline Stroke 2006 37 2 577 617 (Pubitemid 43732031)
95. Diener H.-C., Bogousslavsky J., Brass L. M., Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial The Lancet 2004 364 9431 331 337
96. Yusuf S., Zhao F., Mehta S. R., Chrolavicius S., Tognoni G., Fox K. K., Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation The New England Journal of Medicine 2001 345 7 494 502 (Pubitemid 32758501)